Literature DB >> 12973122

Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma.

Alison W Loren1, Shashank Desai, Robert C Gorman, Lynn M Schuchter.   

Abstract

Donor-derived melanoma is easily transmitted through organ transplants and is highly aggressive in transplant recipients. The best treatment-withdrawal or reduction of immunosuppression-permits tumor rejection but risks allograft rejection. In recipients of nonrenal allografts, the prognosis is particularly grim, with transmission rates and mortality approaching 100%. Retransplantation has been proposed as a possible strategy but has never been performed for a cardiac allograft. This is the first report of cardiac retransplantation and only the second case of retransplantation of any nonrenal organ. Our patient received a heart transplant from a donor found to have occult metastatic melanoma at autopsy. He underwent retransplantation 17 days later. Close clinical and radiographic follow-up reveal no evidence of melanoma 22 months after transplantation. Based on the rapid development of donor-derived melanoma in previous reports, our patient is likely to remain free of donor cancer. Retransplantation and low-dose immunosuppression may have been lifesaving.

Entities:  

Mesh:

Year:  2003        PMID: 12973122     DOI: 10.1097/01.TP.0000080561.31826.FE

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  The dilemma of multiorgan donors with high serum PSA--a pathologist's proposal.

Authors:  Gregor Mikuz; Rodolfo Montironi; Antonio Lopez-Beltran; Gianni Bussolati
Journal:  Virchows Arch       Date:  2006-05-05       Impact factor: 4.064

2.  Melanoma in organ transplant recipients: incidence, outcomes and management considerations.

Authors:  Faisal R Ali; John T Lear
Journal:  J Skin Cancer       Date:  2012-11-25

3.  Cardiac retransplantation is an efficacious therapy for primary cardiac allograft failure.

Authors:  Pavan Atluri; William Hiesinger; Robert C Gorman; Alberto Pochettino; Mariell Jessup; Michael A Acker; Rohinton J Morris; Y Joseph Woo
Journal:  J Cardiothorac Surg       Date:  2008-05-07       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.